Transcend Capital Advisors LLC Decreases Stake in Avantor, Inc. $AVTR

Transcend Capital Advisors LLC lowered its position in Avantor, Inc. (NYSE:AVTR) by 9.1% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 16,981 shares of the company’s stock after selling 1,702 shares during the period. Transcend Capital Advisors LLC’s holdings in Avantor were worth $229,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AVTR. 1832 Asset Management L.P. lifted its holdings in Avantor by 89.8% in the 1st quarter. 1832 Asset Management L.P. now owns 18,127,204 shares of the company’s stock valued at $293,842,000 after purchasing an additional 8,578,493 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in Avantor by 53.2% in the 1st quarter. The Manufacturers Life Insurance Company now owns 14,034,699 shares of the company’s stock valued at $227,502,000 after purchasing an additional 4,876,524 shares in the last quarter. Invesco Ltd. lifted its holdings in Avantor by 19.3% in the 1st quarter. Invesco Ltd. now owns 11,669,411 shares of the company’s stock valued at $189,161,000 after purchasing an additional 1,884,273 shares in the last quarter. Clarkston Capital Partners LLC lifted its holdings in Avantor by 17.8% in the 1st quarter. Clarkston Capital Partners LLC now owns 9,591,950 shares of the company’s stock valued at $155,486,000 after purchasing an additional 1,446,125 shares in the last quarter. Finally, Alliancebernstein L.P. lifted its holdings in Avantor by 28.0% in the 1st quarter. Alliancebernstein L.P. now owns 6,262,052 shares of the company’s stock valued at $101,508,000 after purchasing an additional 1,370,577 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Stock Down 4.7%

Shares of NYSE:AVTR opened at $11.04 on Friday. The business has a 50-day moving average price of $13.36 and a 200 day moving average price of $13.30. The company has a current ratio of 1.49, a quick ratio of 0.67 and a debt-to-equity ratio of 0.65. The company has a market capitalization of $7.53 billion, a price-to-earnings ratio of -84.92, a PEG ratio of 3.81 and a beta of 0.98. Avantor, Inc. has a 12-month low of $10.82 and a 12-month high of $23.70.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $0.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.65 billion. Avantor had a positive return on equity of 10.91% and a negative net margin of 1.25%.The firm’s revenue for the quarter was down 5.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.26 earnings per share. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. Sell-side analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have weighed in on AVTR shares. Robert W. Baird raised their price objective on Avantor from $15.00 to $17.00 and gave the company an “outperform” rating in a report on Friday, October 24th. Evercore ISI reduced their price target on Avantor from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Thursday. Stifel Nicolaus set a $12.00 price target on Avantor and gave the stock a “hold” rating in a report on Monday, August 4th. Morgan Stanley reduced their price target on Avantor from $15.00 to $12.00 and set an “equal weight” rating on the stock in a report on Monday, August 4th. Finally, Raymond James Financial lifted their price target on Avantor from $14.00 to $16.00 and gave the stock an “outperform” rating in a report on Thursday, October 16th. Five analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $14.42.

Insider Activity

In related news, CAO Steven W. Eck sold 3,476 shares of the firm’s stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the completion of the sale, the chief accounting officer directly owned 55,068 shares of the company’s stock, valued at approximately $627,224.52. This trade represents a 5.94% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.20% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.